Terms: = Cervical cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
33059 results:
1. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
Broshkevitch CJ; Barnabas RV; Liu G; Palanee-Phillips T; Rao DW
PLoS One; 2024; 19(5):e0301997. PubMed ID: 38781268
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study.
Traore B; Kassogue Y; Diakite B; Diarra F; Cisse K; Kassogue O; Diarra M; Coulibaly A; Coulibaly B; Diallo H; Diarra Z; Ly M; Maiga A; Sissoko SB; Sissoko AS; Traore CB; Kamate B; Teguete I; Bah S; Dolo G; Gursel DB; Holl J; Hou L; Maiga M
BMC Infect Dis; 2024 May; 24(1):513. PubMed ID: 38778266
[TBL] [Abstract] [Full Text] [Related]
3. Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer.
Wang J; Yu Y; Tan Y; Wan H; Zheng N; He Z; Mao L; Ren W; Chen K; Lin Z; He G; Chen Y; Chen R; Xu H; Liu K; Yao Q; Fu S; Song Y; Chen Q; Zuo L; Wei L; Wang J; Ouyang N; Yao H
Nat Commun; 2024 May; 15(1):4369. PubMed ID: 38778014
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Outcomes and Dosimetric Evaluationof Interstitial Brachytherapyin Gynecological Malignancies.
V VN; Dharmarajan A; Jones J; Yahiya EKN; Muttath G; Sneha N
Gulf J Oncolog; 2024 May; 1(45):69-74. PubMed ID: 38774935
[TBL] [Abstract] [Full Text] [Related]
5. The 8th AJCC classification is inferior to a new neck stage based on intraparotid lymph node in parotid gland cancer.
Han X; Yang C; Tan X; Li Y
BMC Oral Health; 2024 May; 24(1):590. PubMed ID: 38773438
[TBL] [Abstract] [Full Text] [Related]
6. Use superb microvascular imaging to diagnose and predict metastatic cervical lymph nodes in patients with papillary thyroid carcinoma.
Huang T; Huang PT; Luo ZY; Lv JF; Jin PL; Zhang T; Zhao YL; Wang Y; Hong YR
J Cancer Res Clin Oncol; 2024 May; 150(5):268. PubMed ID: 38772976
[TBL] [Abstract] [Full Text] [Related]
7. Human papillomavirus and occupational exposure: The need for vaccine provision for healthcare providers.
Afsar S; Hossain M; Islam M; Simmonds H; Stillwell AA; Butler KA
Hum Vaccin Immunother; 2024 Dec; 20(1):2342622. PubMed ID: 38771122
[TBL] [Abstract] [Full Text] [Related]
8. Scelte gestionali per sostenere e migliorare i programmi di screening oncologico.
Chiereghin A; Squillace L; Pizzi L; Sanna T; Bazzani C; Roti L; Mezzetti F
Epidemiol Prev; 2024; 48(2):158-164. PubMed ID: 38770733
[TBL] [Abstract] [Full Text] [Related]
9. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
[TBL] [Abstract] [Full Text] [Related]
10. IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer.
Guo J; Wang C; Luo N; Wu Y; Huang W; Zhu J; Shi W; Ding J; Ge Y; Liu C; Lu Z; Bast RC; Ai G; Yang W; Wang R; Li C; Chen R; Liu S; Jin H; Zhao B; Cheng Z
BMC Med; 2024 May; 22(1):207. PubMed ID: 38769543
[TBL] [Abstract] [Full Text] [Related]
11. Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
López-Codony V; de Andrés-Pablo Á; Ferrando-Díez A; Fernández-Montolí ME; López-Querol M; Tous S; Ortega-Expósito C; Torrejón-Becerra JC; Pérez Y; Ferrer-Artola A; Sole-Sedeno JM; Grau C; Rupérez B; Saumoy M; Sánchez M; Peremiquel-Trillas P; Bruni L; Alemany L; Bosch FX; Pavón MA
PLoS One; 2024; 19(5):e0304080. PubMed ID: 38768231
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract] [Full Text] [Related]
13. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
14. JAM3 promotes cervical cancer metastasis by activating the HIF-1α/VEGFA pathway.
Peng J; Chen Y; Yin A
BMC Womens Health; 2024 May; 24(1):293. PubMed ID: 38760803
[TBL] [Abstract] [Full Text] [Related]
15. Actions speak louder than words; pediatricians, gynecologists, nurses, and other mothers' perspectives on the human papillomavirus vaccine: an Istanbul multicenter study.
Parlak B; Uğurlucan FG; Gökçay EG
Front Public Health; 2024; 12():1361509. PubMed ID: 38756889
[TBL] [Abstract] [Full Text] [Related]
16. cervical cancer screening practices in HIV positive females - a missing link in health care delivery in Pakistan.
Idrak S; Zaki S; Rasheed F; Javed M; Khalid H; Niaz S; Tahir R; Naseem N
J Pak Med Assoc; 2024 Apr; 74(4):631-640. PubMed ID: 38751253
[TBL] [Abstract] [Full Text] [Related]
17. Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
Falcaro M; Soldan K; Ndlela B; Sasieni P
BMJ; 2024 May; 385():e077341. PubMed ID: 38749552
[TBL] [Abstract] [Full Text] [Related]
18. cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids.
Song H; Jiang H; Hu W; Hai Y; Cai Y; Li H; Liao Y; Huang Y; Lv X; Zhang Y; Zhang J; Huang Y; Liang X; Huang H; Lin X; Wang Y; Yi X
Sci Adv; 2024 May; 10(20):eadl3511. PubMed ID: 38748808
[TBL] [Abstract] [Full Text] [Related]
19. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of cancer screening services provided for people living with HIV in Botswana, 2022-2023.
Mathoma A; Sartorius B; Mahomed S
Health Promot Int; 2024 Jun; 39(3):. PubMed ID: 38742893
[TBL] [Abstract] [Full Text] [Related]
[Next]
